Paxlovid effective against long COVID, study finds.
The research team studied the cases of 56,000 veterans who had contracted the virus. More than 9,000 patients were treated with Paxlovid within five days of infection between March 1 and June 30.
The patients had an average age of 65 and had at least one health issue that put them at higher risk for a more severe COVID, such as older age,While the study only included VA system patients who were mostly white and male, they were a mix of unvaccinated, vaccinated and boosted individuals, as well as those who had previously been infected with“The totality of evidence suggests the need to improve uptake and utilization of nirmatrelvir in the acute phase as a means of not only preventing...
Paxlovid, made by the drug company Pfizer, can be used by people ages 12 and up. Though it's said to work best within five days of symptoms starting, it's not clear whether altering the dose to take higher amounts of the drug or to take it for more days would have more impact,The National Institutes of Health plans to study using Paxlovid in patients who already have long COVID to understand any impact that may have.Copyright © 2022 HealthDay. All rights reserved.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Paxlovid may reduce long covid risk for some patients, VA study findsThe report showed an approximately 25 percent reduction in 10 of the 12 symptoms studied, including the common complaints of lingering fatigue and brain fog.
Read more »
Paxlovid reduces long-COVID risk, VA study findsPfizer's antiviral pill Paxlovid can reduce the risk of long COVID symptoms like organ damage, per a pre-print study released by the Dept. of Veterans Affairs.
Read more »
New VA study finds Paxlovid may cut the risk of long COVIDFor those at high risk, Pfizer's antiviral drug helps stave off severe COVID-19. Now research suggests it may also reduce their chances of long COVID.
Read more »
Paxlovid reduces risk of long Covid, Veterans Affairs study finds | CNNPaxlovid, the antiviral pill that reduces the risk of hospitalization and death from Covid-19, also reduces the risk of long Covid, according to a new study by researchers at the US Department of Veterans Affairs.
Read more »